Compared with normal controls, “EGFR Wild Type/Low PD-L1 expression” NSCLC patients showed poor lymphocyte infiltration and downregulation of immune checkpoint proteins, meeting the criteria for classification as “cold” tumors [54,55]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.